Eligibility for antiamyloid treatment: preparing for disease-modifying therapies for Alzheimer's disease.
Dobson R, Patterson K, Malik R, Mandal U, Asif H, Humphreys R, Payne M, O-Charoenrat E, Huzzey L, Clare A, Green K, Morton M, Sohrabi C, Singh N, Pasupathy A, Patel M, Whiteman S, Maxmin K, Bass N, Gupta B, Cooper C, Marshall C, Weil RS, Mummery CJ.
Dobson R, et al. Among authors: marshall c.
J Neurol Neurosurg Psychiatry. 2024 Aug 16;95(9):796-803. doi: 10.1136/jnnp-2024-333468.
J Neurol Neurosurg Psychiatry. 2024.
PMID: 38862265
Free PMC article.